Jaewon Ryu Buys 1,500 Shares of Teleflex Incorporated (NYSE:TFX) Stock

Key Points

• Jaewon Ryu, a director at Teleflex Incorporated, purchased 1,500 shares at an average price of $115.00, increasing their total ownership by 67.36% to 3,727 shares.
• Teleflex reported an earnings per share (EPS) of $3.73 for the last quarter, exceeding analysts' expectations and showing a revenue growth of 4.2% compared to the previous year.
• The company announced a quarterly dividend of $0.34 per share, with a scheduled payment date of September 15th, which reflects a 1.2% dividend yield.

Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Jaewon Ryu acquired 1,500 shares of Teleflex stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average price of $115.00 per share, with a total value of $172,500.00. Following the purchase, the director owned 3,727 shares in the company, valued at $428,605. This represents a 67.36% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Teleflex Stock Performance

Shares of Teleflex stock traded up $3.35 on Thursday, reaching $115.42. 694,762 shares of the stock were exchanged, compared to its average volume of 807,305. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $249.90. The business has a 50 day moving average price of $118.48 and a two-hundred day moving average price of $135.98. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $5.10 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 1.60 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, beating the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business posted $3.42 EPS. Analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Hedge Funds Weigh In On Teleflex

A number of institutional investors have recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Teleflex in the second quarter worth about $2,464,000. AGF Management Ltd. purchased a new stake in Teleflex in the 2nd quarter worth approximately $2,955,000. True Wealth Design LLC grew its stake in shares of Teleflex by 10,333.3% during the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company's stock worth $37,000 after purchasing an additional 310 shares during the period. Bryn Mawr Trust Advisors LLC purchased a new position in shares of Teleflex during the 2nd quarter valued at approximately $241,000. Finally, Next Capital Management LLC increased its holdings in shares of Teleflex by 32.3% during the 2nd quarter. Next Capital Management LLC now owns 10,423 shares of the medical technology company's stock valued at $1,234,000 after purchasing an additional 2,543 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on TFX shares. Mizuho upped their price target on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Morgan Stanley dropped their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Wells Fargo & Company reduced their target price on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Truist Financial lowered their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Finally, Royal Bank Of Canada boosted their price target on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a sell rating, eight have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $141.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.